University of Pennsylvania - Perelman Center for Advanced Medicine — Philadelphia, Pennsylvania

University of Pennsylvania - Perelman Center for Advanced Medicine is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.

Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.

University of Pennsylvania - Perelman Center for Advanced Medicine has participated in 9 clinical trials with 5 currently active.

Therapeutic areas: Fibrodysplasia Ossificans Progressiva, Glioblastoma, Multifocal Motor Neuropathy (MMN).

Sponsors: Ashibio Inc, Global Coalition for Adaptive Research, argenx.

Sponsor Feasibility Report

Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Pennsylvania - Perelman Center for Advanced Medicine?

University of Pennsylvania - Perelman Center for Advanced Medicine has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Pennsylvania - Perelman Center for Advanced Medicine conducted?

University of Pennsylvania - Perelman Center for Advanced Medicine has 9 clinical trials on record, with 5 currently active. Their work covers Fibrodysplasia Ossificans Progressiva, Glioblastoma, Multifocal Motor Neuropathy (MMN).

Is University of Pennsylvania - Perelman Center for Advanced Medicine accredited by Crixeo Health?

Yes — University of Pennsylvania - Perelman Center for Advanced Medicine holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about University of Pennsylvania - Perelman Center for Advanced Medicine?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.